Jump to content

4-AcO-MiPT

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 18:33, 3 August 2016 (Added UNII from FDA SRS). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

4-AcO-MiPT
Names
IUPAC name
[3-[2-[Isopropyl(methyl)amino]ethyl]-1H-indol-4-yl] acetate
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3 checkY
    Key: CIDMXLOVFPIHDS-UHFFFAOYSA-N checkY
  • InChI=1/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3
    Key: CIDMXLOVFPIHDS-UHFFFAOYAP
  • CC(N(CCC1=CNC2=C1C(OC(C)=O)=CC=C2)C)C
Properties
C16H22N2O2
Molar mass 274.364 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

4-AcO-MiPT (4-acetoxy-N-methyl-N-isopropyltryptamine or mipracetin) is a psychedelic tryptamine. It is closely related to O-acetylpsilocin and MiPT.

There is very little information on the human pharmacology or toxicity of 4-AcO-MiPT, although analytical methods have been developed for its detection.[1][2]

Drug prohibition laws

Sweden

Sveriges riksdags health ministry Statens folkhälsoinstitut classified 4-AcO-MiPT as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Nov 1, 2005, in their regulation SFS 2005:733 listed as 4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT), making it illegal to sell or possess.[3]

References

  1. ^ TAKAHASHI, M; NAGASHIMA, M; SUZUKI, J; SETO, T; YASUDA, I; YOSHIDA, T (15 February 2009). "Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry". Talanta. 77 (4): 1245–1272. doi:10.1016/j.talanta.2008.07.062.
  2. ^ Noorizadeh, Hadi; Farmany, Abbas; Noorizadeh, Mehrab (20 September 2011). "Application of GA–KPLS and L–M ANN calculations for the prediction of the capacity factor of hazardous psychoactive designer drugs". Medicinal Chemistry Research. 21 (9): 2680–2688. doi:10.1007/s00044-011-9794-y.
  3. ^ http://www.notisum.se/rnp/sls/sfs/20050733.pdf
Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=4-AcO-MiPT&oldid=732858755"